SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting here, Steven D. Vold, MD, discusses the implementation of the Lumenis Selecta Trio laser platform at Vold Vision in Fayetteville, Ark.
Uncategorized
Uncategorized
Eleven Biotherapeutics Reports First Quarter 2015 Financial Results
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics Reports First Quarter 2015 Financial Results
Uncategorized
Clearside Biomedical, Inc. to Report Efficacy and Safety Results in Non-infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide at 2015 ARVO Meeting
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, which develops drug therapies to treat eye diseases, will present its Phase 1/2 clinical trial results May 5 at the Association for Research and Vision in Ophthalmology meeting.
Uncategorized
Magellan Health Reports First Quarter 2015 Financial Results Updates Guidance
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today reported financial results for the first quarter of 2015, as summarized below.
Uncategorized
Monroe Capital Expands Credit Facility to Luxury Optical Holdings
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC today announced an increase in the credit facility to Luxury Optical Holdings (“LOH”) to support continued growth of the business. LOH is a portfolio company of aPriori Capital Partners and Goode Partners. Based in Las Vegas, Nevada, Luxury Optical Holdings is the leading retailer of luxury eyewear with specialty boutiques in key markets across the United States. LOH’s key retail concepts include Robert Marc, Optica, Scene, Morgenthal Frederics, Dava
Uncategorized
Publication Exclusive: A question for residents — Comprehensive ophthalmology or subspecialty fellowship?
One of our missions is to promote resident education, including introducing residents to the process of speaking from the podium and contributing as authors in medical journals. This month, Dr. Phelan Piehota and Dr. Andrew Strand, residents at the Ohi…